For example, there are genetic alterations involving the BCR-dependent NF-κ B signaling pathway in the MCD and BN2 subtypes of DLBCL, and involving the PI3K pathway in the ST2 and EZB subtypes (19–21). Here, BCR is linked to diffuse large B-cell lymphoma.